Get the latest on Intellia Therapeutics’ Q3 2025 earnings: clinical hold impacts, nex-z safety updates, lonvo-z progress, and financial outlook.
Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, ...
Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Crane NXT ...
CONMED Corporation (NYSE: CNMD) Q3 2025 Earnings Call Transcript November 5, 2025 CONMED Corporation beats earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback